Predicted mutation strength of nontruncating PKD1 mutations AIDS genotype-phenotype correlations in autosomal dominant polycystic kidney disease

Journal of the American Society of Nephrology

Volumn 27, Issue 9, 2016, Pages 2872-2884

  Heyer, Christina M ^a   Sundsbak, Jamie L ^a   Abebe, Kaleab Z ^b   Chapman, Arlene B ^c   Torres, Vicente E ^a   Grantham, Jared J ^d   Bae, Kyongtae T ^e   Schrier, Robert W ^f   Perrone, Ronald D ^g   Braun, William E ^h   Steinman, Theodore I ⁱ   Mrug, Michal ^j   Yu, Alan S L ^d   Brosnahan, Godela ^e   Hopp, Katharina ^a   Irazabal, Maria V ^a   Bennett, William M ^k   Flessner, Michael F ^l   Moore, Charity G ^m   Landsittel, Douglas ^b   Harris, Peter C ^a   more..

^a MAYO CLINIC   (United States)

^b Center for Research on Health Care   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g TUFTS MEDICAL CENTER   (United States)

^h LERNER RESEARCH INSTITUTE   (United States)

ⁱ BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^j University of Alabama at Birmingham   (United States)

^k LEGACY GOOD SAMARITAN HOSPITAL   (United States)

^l NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^m LEVINE CANCER INSTITUTE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; POLYCYSTIN 1; POLYCYSTIC KIDNEY DISEASE 1 PROTEIN; POLYCYSTIN;

ADULT; ARTICLE; CORRELATION ANALYSIS; DISEASE SEVERITY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; KIDNEY FUNCTION; KIDNEY POLYCYSTIC DISEASE; LIVER CYST; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; PRIORITY JOURNAL; SEX DIFFERENCE; FORECASTING; GENETIC ASSOCIATION STUDY; GENETICS; GENOTYPE; MIDDLE AGED; MUTATION; PHENOTYPE;

ADULT; FEMALE; FORECASTING; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; TRPP CATION CHANNELS;

EID: 84981157778     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015050583     Document Type: Article

References (36)

1. Torres VE, Harris PC, Pirson Y: Autosomal dominant polycystic kidney disease. Lancet 369: 1287-1301, 2007
2. Harris PC, Torres VE: Polycystic kidney disease. Annu RevMed 60: 321-337, 2009
3. Rossetti S,ConsugarMB, ChapmanAB, Torres VE,Guay-Woodford LM, Grantham JJ, Bennett WM, Meyers CM, Walker DL, Bae K, Zhang QJ, Thompson PA,Miller JP, Harris PC; CRISP Consortium: Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 18: 2143-2160, 2007
4. Audrézet MP, Cornec-Le Gall E, Chen JM, Redon S, Quéré I, Creff J, Bénech C, Maestri S, Le Meur Y, Férec C: Autosomal dominant polycystic kidney disease: Comprehensive mutation analysis of PKD1 and PKD2 in 700 unrelated patients. Hum Mutat 33: 1239-1250, 2012
5. Hateboer N, v Dijk MA, Bogdanova N, Coto E, Saggar-Malik AK, San Millan JL, Torra R, BreuningM, Ravine D: Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet 353: 103-107, 1999
6. Cornec-LeGall E, AudrézetMP, Chen JM,HourmantM,Morin MP, Perrichot R, Charasse C, Whebe B, Renaudineau E, Jousset P, Guillodo MP, Grall-Jezequel A, Saliou P, Férec C, Le Meur Y: Type of PKD1 mutation influences renal outcome in ADPKD. J AmSocNephrol 24: 1006-1013, 2013
7. Grantham JJ, Chapman AB, Torres VE: Volume progression in autosomal dominant polycystic kidney disease: The major factor determining clinical outcomes. Clin J Am Soc Nephrol 1: 148-157, 2006
8. Harris PC, Bae K, Rossetti S, Torres VE,Grantham JJ,Chapman A,Guay-Woodford L, King BF,Wetzel LH, Baumgarten D, Kenney PJ, Consugar M, Klahr S, Bennett WM, Meyers CM, Zhang Q, Thompson PA, Zhu F, Miller JP, ConsortiumC: Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 17: 3013-3019, 2006
9. Autosomal Dominant Polycystic Kidney Disease Mutation Database. Available at: http://pkdb. mayo. edu. Accessed October 15, 2015
10. Rossetti S, Burton S, Strmecki L, Pond GR, San Millán JL, Zerres K, Barratt TM, Ozen S, Torres VE, Bergstralh EJ, Winearls CG, Harris PC: The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J AmSocNephrol 13: 1230-1237, 2002
11. Rossetti S, Chauveau D, Kubly V, Slezak JM, Saggar-Malik AK, Pei Y, Ong AC, Stewart F,WatsonML, Bergstralh EJ, Winearls CG, Torres VE, Harris PC: Association ofmutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 361: 2196-2201, 2003
12. Rossetti S, Kubly VJ, ConsugarMB, Hopp K, Roy S, Horsley SW, Chauveau D, Rees L, Barratt TM, van't Hoff WG, Niaudet P, Torres VE, Harris PC: Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney Int 75: 848-855, 2009
13. Vujic M, Heyer CM, Ars E, Hopp K, Markoff A, Orndal C, Rudenhed B, Nasr SH, Torres VE, Torra R, Bogdanova N, Harris PC: Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD. J Am Soc Nephrol 21: 1097-1102, 2010
14. Bergmann C, von Bothmer J, Ortiz Brüchle N, Venghaus A, Frank V, Fehrenbach H, Hampel T, Pape L, Buske A, Jonsson J, Sarioglu N, Santos A, Ferreira JC, Becker JU, Cremer R, Hoefele J, BenzMR,Weber LT, Buettner R, Zerres K: Mutations in multiple PKD genes may explain early and severe polycystic kidney disease. J Am Soc Nephrol 22: 2047-2056, 2011
15. Audrézet MP, Corbiere C, Lebbah S, Morinière V, Broux F, Louillet F, FischbachM, Zaloszyc A, Cloarec S, Merieau E, Baudouin V, Deschênes G, Roussey G, Maestri S, Visconti C, Boyer O, Abel C, Lahoche A, Randrianaivo H, Bessenay L, Mekahli D, Ouertani I, Decramer S, Ryckenwaert A, Cornec-Le Gall E, Salomon R, Ferec C, Heidet L: Comprehensive PKD1 and PKD2 mutation analysis in prenatal autosomal dominant polycystic kidney disease [published online ahead of print July 2, 2015]. J AmSoc Nephrol doi:ASN. 2014101051
16. Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Bae KT, Baumgarten DA, Kenney PJ, King BF JrGlockner JF, Wetzel LH, BrummerME,O'NeillWC, RobbinML, BennettWM, Klahr S, Hirschman GH, Kimmel PL, Thompson PA, Miller JP; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease cohort: Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort. Kidney Int 64: 1035-1045, 2003
17. Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF Jr., Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, Zhu F, Miller JP; CRISP Investigators: Volume progression in polycystic kidney disease. N Engl J Med 354: 2122-2130, 2006
18. Chapman AB, Torres VE, Perrone RD, Steinman TI, Bae KT, Miller JP, Miskulin DC, Rahbari Oskoui F,Masoumi A, Hogan MC,Winklhofer FT, BraunW, Thompson PA, Meyers CM, Kelleher C, Schrier RW: The HALT polycystic kidney disease trials: Design and implementation. Clin J Am Soc Nephrol 5: 102-109, 2010
19. Schrier RW, Abebe KZ, Perrone RD, Torres VE, BraunWE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Bae KT, Moore CG, Chapman AB; HALT-PKD Trial Investigators: Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med 371: 2255-2266, 2014
20. Torres VE, Abebe KZ, Chapman AB, Schrier RW, Braun WE, Steinman TI,Winklhofer FT, BrosnahanG,Czarnecki PG,HoganMC,MiskulinDC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Moore CG, Perrone RD; HALT-PKD Trial Investigators: Angiotensin blockade in late autosomal dominant polycystic kidney disease. NEngl JMed 371: 2267-2276, 2014
21. Irazabal MV, Rangel LJ, Bergstralh EJ, Osborn SL, Harmon AJ, Sundsbak JL, Bae KT, Chapman AB, GranthamJJ,Mrug M, HoganMC, El-Zoghby ZM, Harris PC, Erickson BJ, King BF, Torres VE; CRISP Investigators: Imaging classification of autosomal dominant polycystic kidney disease: A simplemodel for selecting patients for clinical trials. J Am Soc Nephrol 26: 160-172, 2015
22. Chapman AB, Bost JE, Torres VE, Guay-Woodford L, Bae KT, Landsittel D, Li J, King BF, Martin D, Wetzel LH, Lockhart ME, Harris PC, Moxey-Mims M, Flessner M, Bennett WM, Grantham JJ: Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol 7: 479-486, 2012
23. Ravine D, Walker RG, Gibson RN, Forrest SM, Richards RI, Friend K, Sheffield LJ, Kincaid-Smith P, Danks DM: Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease. Lancet 340: 1330-1333, 1992
24. Cornec-Le Gall E, Audrézet MP, Rousseau A, Hourmant M, Renaudineau E, Charasse C, Morin MP, Moal MC, Dantal J, Wehbe B, Perrichot R, Frouget T, Vigneau C, Potier J, Jousset P, Guillodo MP, Siohan P, Terki N, Sawadogo T, Legrand D, Menoyo-Calonge V, Benarbia S, Besnier D, Longuet H, Férec C, Le Meur Y: The PROPKD Score: A new algorithm to predict renal survival in autosomal dominant polycystic kidney disease [published online ahead of print July 6, 2015]. J Am Soc Nephrol doi:ASN. 2015010016
25. Gabow PA, Johnson AM, Kaehny WD, KimberlingWJ, Lezotte DC, Duley IT, Jones RH: Factors affecting the progression of renal disease in autosomaldominant polycystic kidney disease. Kidney Int 41: 1311-1319, 1992
26. Magistroni R, He N, Wang K, Andrew R, Johnson A, Gabow P, Dicks E, Parfrey P, Torra R, San-Millan JL, Coto E, VanDijkM, Breuning M, Peters D, Bogdanova N, Ligabue G, Albertazzi A, Hateboer N, Demetriou K, Pierides A, Deltas C, St George-Hyslop P, Ravine D, Pei Y: Genotyperenal function correlation in type 2 autosomal dominant polycystic kidney disease. J Am Soc Nephrol 14: 1164-1174, 2003
27. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J; CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration): A new equation to estimate glomerular filtration rate. Ann InternMed 150: 604-612, 2009
28. Hogan MC, Abebe K, Torres VE, Chapman AB, Bae KT, Tao C, Sun H, Perrone RD, Steinman TI, Braun W, Winklhofer FT, Miskulin DC, Rahbari-Oskoui F, Brosnahan G, Masoumi A, Karpov IO, Spillane S, Flessner M,Moore CG, Schrier RW: Liver involvement in early autosomaldominant polycystic kidney disease. Clin GastroenterolHepatol 13: 155-64. e6, 2015
29. Hughes J,Ward CJ, Peral B, Aspinwall R, Clark K, San Millán JL,Gamble V, Harris PC: The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 10: 151-160, 1995
30. Paul BM, Consugar MB, Ryan Lee M, Sundsbak JL, Heyer CM, Rossetti S, Kubly VJ, Hopp K, Torres VE, Coto E, Clementi M, Bogdanova N, de Almeida E, BichetDG, Harris PC: Evidence of a third ADPKD locus is not supported by re-analysis of designated PKD3 families. Kidney Int 85: 383-392, 2014
31. Harris PC, Rossetti S: Molecular diagnostics for autosomal dominant polycystic kidney disease. Nat Rev Nephrol 6: 197-206, 2010
32. Grantham JJ, Mulamalla S, Swenson-Fields KI: Why kidneys fail in autosomal dominant polycystic kidney disease. Nat Rev Nephrol 7: 556-566, 2011
33. Hopp K, Ward CJ, Hommerding CJ, Nasr SH, Tuan HF, Gainullin VG, Rossetti S, Torres VE, Harris PC: Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity. J Clin Invest 122: 4257-4273, 2012
34. Gainullin VG,Hopp K,Ward CJ, Hommerding CJ, Harris PC: Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner. J Clin Invest 125: 607-620, 2015
35. Cai Y, Fedeles SV, Dong K, Anyatonwu G, Onoe T, Mitobe M, Gao JD, Okuhara D, Tian X, Gallagher AR, Tang Z, Xie X, Lalioti MD, Lee AH, Ehrlich BE, Somlo S: Altered trafficking and stability of polycystins underlie polycystic kidney disease. J Clin Invest 124: 5129-5144, 2014
36. Consugar MB, Wong WC, Lundquist PA, Rossetti S, Kubly VJ, Walker DL, Rangel LJ, Aspinwall R, Niaudet WP, Ozen S, David A, Velinov M, Bergstralh EJ, Bae KT, Chapman AB, Guay-Woodford LM, Grantham JJ, Torres VE, Sampson JR, Dawson BD, Harris PC; CRISP Consortium: Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. Kidney Int 74: 1468-1479, 2008